Article

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disorders

2016-12-23

Abstract excerpt

Our knowledge of disease genetics has advanced rapidly during the past decade, with the advent of high-throughput genotyping technologies such as genome-wide association studies (GWAS). However, few methodologies were developed and systemic studies performed to identify novel drug candidates utilizing GWAS data. In this study we focus on drug repositioning, which is a cost-effective approach to shorten the develop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 24b1ace0-23da-5c73-a6ab-117a6407565a
DOI: 10.1101/096503

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disordersDOI 10.1101/096503Read

Translating GWAS Findings Into Therapies For Depression And Anxiety Disorders: Drug Repositioning Using Gene-Set Analyses Reveals Enrichment Of Psychiatric Drug ClassesSemantic proximity Read

Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds.Semantic proximity Read

Disease comorbidity-guided drug repositioning: a case study in schizophrenia.Semantic proximity Read

Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Semantic proximity Read

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and CompoundsSemantic proximity Read

Using genome-wide association results to identify drug repurposing candidatesSemantic proximity Read

PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery.Semantic proximity Read

Application of GWAS summary data and drug-induced gene expression profiles of neural progenitor cells in psychiatric drug prioritization analysis.Semantic proximity Read

Advancing the use of genome-wide association studies for drug repurposing.Semantic proximity Read

Pathway and network embedding methods for prioritizing psychiatric drugsSemantic proximity Read

Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.Semantic proximity Read

Linking GWAS to pharmacological treatments for psychiatric disordersSemantic proximity Read